Changes Jan. 6, 2020
The following is a list of changes on monitored regulatory lists which occurred between Jan. 3, 2020 and Jan. 6, 2020.
Legend
- regulatory records added to the list
- regulatory records removed from the list
- changed regulatory records
For changed records, you can see the history of changes by following the link to the corresponding regulatory record.
Registrants
- ''amyl nitrite'', mixed isomers
- (+)-tartaric acid
- (+)-tartaric acid
- (1,2-dimethylpropyl)-5-methyl-pyrazole-4-carboxylic acid
- (1,2-dioxoethylene)bis(iminoethylene) bis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate]
- (1-((2'-(2H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-butyl-4-chloro-1H-imidazol-5-yl)methanol
- (1-methyl-1,2-ethanediyl)bis[oxy(methyl-2,1-ethanediyl)] diacrylate
- (1R)-[7,7-dimethyl-2-oxobicyclo[2.2.1]hept-1-yl]methanesulphonic acid
- (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl (2R,5R)-5-hydroxy-1,3-oxathiolane-2-carboxylate
- (1S)-1,5-anhydro-2,3,4,6-tetrakis-O-(2,2-dimethylpropanoyl)-1-(3-{[5-(4-fluorophenyl)-2-thienyl]methyl}-4-methylphenyl)-D-glucitol
- (1S,3R,5R,7S)-3-Aminoadamantan-1-ol
- (2-(tert-butoxy)-2-oxoethyl)triphenylphosphonium chloride
- (2-ethyl-2-methyl-1,3-dioxolan-4-yl)methyl acrylate
- (2-hydroxyethyl)ammonium mercaptoacetate
- (2-hydroxypropyl)trimethylammonium 2-ethylhexanoate
- (2-hydroxypropyl)trimethylammonium formate
- (2-methoxyethyl)benzene
- (2-methoxymethylethoxy)propanol
- (2R,3R)-2,3-bis[(4-methoxybenzoyl)oxy]butanedioic acid
- (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate
- (2S)-1-(tert-butoxycarbonyl)-4-oxopyrrolidine-2-carboxylic acid
- (2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoic acid
- (2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoic acid
- (2S)-[[(benzyloxy)carbonyl]amino](cyclohexyl)acetic acid
- (2S)-[[(benzyloxy)carbonyl]amino](cyclohexyl)acetic acid
- (2S,3S)-3-amino-N-cyclopropyl-2-hydroxyhexanamide hydrochloride
- (2Z)-but-2-ene-1,4-diyl diacetate
- (3 β, 5 α, 6β)-3-(acetyloxy)-5-bromo-6-hydroxy-androstan-17-one
- (3,4-dihydroxyphenyl)(phenyl)methanone
- (3-acetyloxy-2,2-dimethylpropyl) acetate
- (3-ammonio-4-methoxyphenyl)(2-hydroxyethyl)ammonium sulphate
- (3-chloropropyl)diethoxymethylsilane
- (3-chloropropyl)dimethoxymethylsilane
- (3-chloropropyl)triethoxysilane
- (3-methacrylamidopropyl)trimethylammonium chloride
- (3E)-dec-3-en-2-one
- (3R,6R)-3,6-dimethyl-1,4-dioxane-2,5-dione
- (3S)-3-hydroxypyrrolidin-2-one
- (3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone
- (3S-cis)-3,6-dimethyl-1,4-dioxane-2,5-dione
- (3aR,8aS,8bS)-1,3-Dibenzyl-2-oxodecahydrothieno[1',2':1,2]thieno[3,4-d]imidazol-5-ium bromide
- (4-acetamido-2,2,6,6-tetramethyl-1-piperidinyl)oxidanyl; N-(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl)acetamide
- (4-benzylpiperazin-1-yl)(cyclopropyl)methanone hydrochloride
- (4-carboxybutyl)triphenylphosphonium bromide
- (4-nitrophenyl)methanesulfonyl chloride
- (4R)-1-(tert-butoxycarbonyl)-4-hydroxy-L-proline
- (4R,6R)-4-Hydroxy-2,2,6-trimethylcyclohexanone / 60046-50-6
- (4R,6R)-6-[2-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-Dioxane-4-acetic acid 1,1-dimethylethyl ester
- (4aR*,8aR*)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-one
- (5Z)-5-(2-Methylpropylidene)imidazolidine-2,4-dione
- (5Z)-5-Benzylideneimidazolidine-2,4-dione
- (6-Bromo-2-pyridinyl)(4-methylphenyl)methanone
- (6R-trans)-7-amino-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (6R-trans)-7-amino-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-ium chloride
- (Benzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate
- (E)-1,4-dibromobut-2-ene
- (R)-1,1'-Binaphthalene-2,2'-diol
- (R)-1-chloro-2,3-epoxypropane
- (R)-2-methylpropane-2-sulfinamide
- (R)-5-(2-Aminopropyl)-2-methoxybenzenesulfonamide
- (R)-5-Bromo-3-[(1-methyl-2-pyrrolidinyl)methyl]-1H-indol oxalate
- (R)-p-mentha-1,8-diene
- (R)-p-mentha-1,8-diene
- (R,S)-2-azabicyclo[2.2.1]hept-5-en-3-one
- (R,S)-2-azabicyclo[2.2.1]hept-5-en-3-one
- (Reaction product of 4-[2-(4-hydroxyphenyl)propan-2-yl]phenol, 2-(2-hydroxyethylamino)ethanol and formaldehyde), propoxylated
- (S)-(4,5-dihydro-5-thioxo-1,3,4-thiadiazol-2-yl) benzenecarbothioate
- (S)-(4,5-dihydro-5-thioxo-1,3,4-thiadiazol-2-yl) benzenecarbothioate
- (S)-1,1-diphenyl-1,2-propanediol
- (S)-2-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(1-trityl-1H-imidazol-4-yl)propanamido)-2-methylpropanoic acid
- (S)-2-(5-Oxo-3-propyl-1,2-dihydropyrrol-1-yl) butyramide
- (S)-2-Amino-6-propionylamino-4,5,6,7-tetrahydrobenzothiazole
- (S)-2-Amino-6-propylamino-4,5,6,7-tetrahydrobenzothiazole
- (S)-2-Amino-butylacetamide
- (S)-2-Amino-butylacetamide
- (S)-3-(acetylthio)-2-methylpropionic acid
- (S)-3-Amino-2,3,4,5-tetrahydro-2-oxo-1H-1-benazepine-1-acetic acid 1,1-dimethyl ethyl ester
- (S)-3-Amino-2,3,4,5-tetrahydro-2-oxo-1H-1-benazepine-1-acetic acid 1,1-dimethyl ethyl ester
- (S)-3-benzyloxycarbonyl-1,2,3,4-tetrahydro-isoquinolinium 4-methylbenzenesulfonate
- (S)-3-benzyloxycarbonyl-1,2,3,4-tetrahydro-isoquinolinium 4-methylbenzenesulfonate
- (Z)-2-(2-t-butoxycarbonylamino-4-thiazolyl)pent-2-enoic acid
- (Z)-2-(2-t-butoxycarbonylamino-4-thiazolyl)pent-2-enoic acid
- (Z)-3-hexenyl salicylate
- (Z)-3-hexenyl salicylate
- (Z)-N-octadecyldocos-13-enamide
- (Z)-N-octadecyldocos-13-enamide
- (Z)-but-2-enedioic acid;N-[2-(dimethylamino)ethyl]-5-(dithiolan-3-yl)pentanamide
- (Z)-cyclooctene
- (Z)-cyclooctene
- (Z)-hex-3-enyl (Z)-hex-3-enoate
- (Z)-hex-3-enyl (Z)-hex-3-enoate
- (Z)-hex-3-enyl acetate
- (Z)-hex-3-enyl acetate
- (Z)-octadec-9-enol
- (Z)-octadec-9-enol
- (Z)-tetradec-9-enol
- (Z)-tetradec-9-enol
- (benzothiazol-2-ylthio)succinic acid
- (carboxylatomethyl)dimethyltetradecylammonium